drugset / Trial / NCT06824519
Clinical Trials of Quadrivalent Influenza Vaccine
RandomizedParallel-groupTriple-blindPrevention
Summary
This clinical trial adopts a seamless design of phase I/II, conducted in two stages: phase I and phase II. Phase I is the age/dose ramp up stage, and phase II is the dose expansion stage.The purpose of this clinical trial is to evaluate the safety and tolerability of different doses of Influenza Vaccine (Split Virion), Inactivated, Quadrivalent, ZFA02 Adjuvant，explore the immunogenicity of the vaccine, and determine the appropriate dose for later clinical trials of this product.
Timeline
- Start
- 2025-05-08
- Primary completion
- 2025-08-05
- Completion
- 2026-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Influenza Vaccine (Split Virion), Inactivated, Quadrivalent | Vaccine | — | — |
| Subject | Influenza Vaccine (Split Virion), Inactivated, Quadrivalent, ZFA02 Adjuvant | Vaccine | — | — |